Blood and blood-related infections and chronic kidney disease (CKD) are considered major community health issues worldwide. According to a report by Britain’s National Kidney Federation published in 2014, more than 25,000 patients receive dialysis treatment every year and the number is anticipated to reach approximately 42,020 by the end of 2018. Hemodialysis, also known as kidney dialysis or merely dialysis, is a method of purifying the patient’s blood by using a dialysis machine. The number of patients affected by CKD is on the rise across the world. Therefore, the demand for hemodialysis chairs is increasing. The demand for these chairs has risen rapidly over the last few years.

Hypertension and diabetes are key causes of chronic kidney disease (CKD). According to researchers, roughly 30%–40% of patients with chronic diabetes have risk of developing CKD in their lifetime. In comparison, high-blood pressure patients account for approximately 20% of all cases. For example, according to 2015 research findings by the National Health Survey, almost 15% of urban Indians are affected by chronic kidney disease (CKD).

The global hemodialysis chairs market is estimated to expand rapidly in the next few years. A major driver of the market is increase in elderly population. The rate of incidence of severe renal disease, also known as final-stage CKD, is high among people aged between 48 and 60 years. These CKD patients require precise and longer treatments. CKD treatment ranges from dieting to regular dialysis and drug therapy. Public and private health care service companies have started implementing national awareness programs, due to low awareness about CKD diagnosis. This is likely to propel the global hemodialysis chairs market during the forecast period. Incidence as well as prevalence of CKD and blood-related diseases varies from region to region and country to country. Moreover, increase in unmet demand is anticipated to boost the global hemodialysis chairs market during the forecast period. For example, according to current research findings, the number of persons suffering from diabetes in India is estimated to get more than double by 2040. Advancements in technology and increase in per capita income are some of the factors that are estimated to drive the hemodialysis chairs market in developing countries, such as India, in the near future. However, factors such as limited reimbursement policies, high cost of treatment, and adverse effects caused by lack of hygiene and re-use of hemodialysis supplies are restraining the global hemodialysis chairs market.

The global hemodialysis chairs market can be segmented based on product, end-user, and region. Based on product, the market can be classified into electric hemodialysis chairs and manual hemodialysis chairs. Based on position and technique, the electric hemodialysis chairs segment can be sub-divided into multi-positional chairs, fold-away arm supports, sliding footboards, and others. In terms of end-user, the global hemodialysis chairs market can be categorized into hospitals, ambulatory surgical centers, and home care settings. The hospitals segment is estimated to dominate the market in the next few years, followed by the home care settings segment.

Based on region, the global hemodialysis chairs market can be classified into Europe, Asia Pacific, Middle East & Africa, North America, and Latin America. North America leads the global market. The market in Asia Pacific, which includes countries such as India, China, and the Philippines, is projected to be a lucrative market for hemodialysis chairs in the next few years. This is attributable to increase in attention of key players toward the region, rise in the number of dialysis centers operating independently, increase in the pool of CKD patients, increase in government health care expenditure, and growth in the number of programs to make available new and technologically advanced products for dialysis facilities.

Some of the major players operating in the global hemodialysis chairs market are Baxter International, Inc., Digiterm (Hungary), Euroclinic, DaVita Healthcare Partners Inc., Medi-Plinth, and Acime-Frame.

The global infection control market has been segmented based on equipment type, infection control services, infection prevention supplies, end-user, and region. In terms of equipment type, the global market can be classified into sterilization equipment, washing/disinfecting equipment, and others. Based on infection control services, the global infection control market can be bifurcated into infectious waste disposal services and contract sterilization. In terms of infection prevention supplies, the global market can be divided into infectious waste disposal, disinfectants, sterilization supplies, safety enhanced medical devices, and protective apparel & textiles. Based on end-user, the global infection control market can be categorized into hospitals & clinics, medical device companies, pharmaceutical companies, life sciences industry, food industry, and others.

In terms of region, the global infection control market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for major market share in 2017 owing to advanced health care infrastructure and rise in demand for infection control services in the region. Additionally, technological advancements in equipment utilized in sterilization procedures drive the market in the region. The U.S. accounted for major share of the infection control market in North America in terms of revenue in 2017, followed by Canada. Germany, France, and the U.K. held majority share of the infection control market in Europe in 2017. However, the infection control market in Asia Pacific is expected to expand at a high CAGR during the forecast period. This is due to increase in incidence of HAIs and rise in awareness about various types of infections in the region. Moreover, high disposable income, rise in demographics and economies in developing countries such as India and China are anticipated to fuel the growth in the infection control market in Asia Pacific.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

A complete backdrop analysis, which includes an assessment of the parent market

Important changes in market dynamics

Market segmentation up to the second or third level

Historical, current, and projected size of the market from the standpoint of both value and volume

Reporting and evaluation of recent industry developments

Market shares and strategies of key players

Emerging niche segments and regional markets

An objective assessment of the trajectory of the market

Recommendations to companies for strengthening their foothold in the market

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.